New SPH & HRAC Study Maps Complex Journey Through Homelessness In Final Pathways Report
A new report from Portland State University’s Homelessness Research and Action Collaborative (HRAC) and the OHSU-PSU School of Public Health... Read More
New Study Highlights Barriers to Tribal Public Health Data Access
Assistant Professor Kathleen Conte of the OHSU-PSU School of Public Health has co-authored a new publication examining critical gaps in... Read More
Advancing Equity in Cancer Clinical Trials
On April 7, 2026, Assistant Professor Kristi Tredway represented the OHSU-PSU School of Public Health at the Cancer Clinical Trial... Read More
Rates of gun-related suicides in Oregon are higher than national average
Oregon Public Broadcasting’s Think Out Loud recently featured Becca Valek, a research project coordinator at OHSU’s Gun Violence Prevention Center,... Read More
SPH Faculty and Students Present Cancer Research at AACR Annual Meeting
Last month, faculty and doctoral scholars from the OHSU‑PSU School of Public Health shared cancer prevention and screening research at... Read More
Unhoused Individuals Want Permanent Housing, Face Steep Financial Barriers
We are excited to highlight new research featuring Assistant Professor Kathleen Conte, who teaches in the MPH Health Management and... Read More
Ready. Set. Action! Celebrating National Public Health Week at the OHSU-PSU School of Public Health
The OHSU-PSU School of Public Health is proud to announce a week-long series of events in celebration of National Public... Read More
Kathleen Carlson’s New Study Examines How Oregon’s ERPO Law Addresses Mass Violence Threats
A recently published study by OHSU-PSU School of Public Health faculty member Kathleen F. Carlson, PhD, sheds new light on... Read More
Ryan Petteway Presents at 2025 APHA Annual Meeting on Epistemological Racism in Epidemiology
Ryan Petteway, PhD, MPH, Associate Professor of Community Health & Health Promotion at the OHSU-PSU School of Public Health, recently... Read More
OHSU Research Drives FDA Approval For Novel Use of Anemia Drug In Brain Cancer Imaging
The Food and Drug Administration has approved ferumoxytol, known clinically as FERABRIGHT™, as a contrast agent physicians can use to... Read More